Global mRNA-based oncology therapies market expected to reach $2 billion by 2029: GlobalData, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

BioNTech is expected to lead the market with projected sales of $885 million and a 44.6 per cent share by 2029. Melanoma remains the primary focus of advanced mRNA-based therapies, with promising results in Phase II trials., BioNTech is expected to lead the market with projected sales of $885 million and a 44.6 per cent share by 2029. Melanoma remains the primary focus of advanced mRNA-based therapies, with promising results in Phase II trials., , Read More